Negri A L, Alvarez Quiroga M, Bravo M, Fradinger E, Jacobo de Marino A, Bogado C E, Zanchetta J R
Instituto de Investigaciones Metabólicas, Facultad de Medicina, Universidad del Salvador, Buenos Aires, Argentina.
Nefrologia. 2003 Jul-Aug;23(4):327-32.
The conventional intact PTH assays detect not only PTH 1-84 but also inactive fragments (as PTH 7-84) that accumulate in renal failure. There has been a recent development of a new PTH assay that measures only true 1-84 PTH (Whole PTH or CAP assay, Scantibodies). As 7-84 PTH fragment is antagonistic on bone effects of 1-84 PTH, Moniere-Faugere has suggested that 1-84/7-84 PTH ratio less than 1 is predictive of low turnover. We evaluated the usefulness of CAP assay and the 1-84/7-84 PTH ratio as markers of bone turnover in a groups of 24 patients in peritoneal dialysis (PD). Patients were classified as having low bone turn over if they had a Total PTH (similar to intact PTH) of less than 100 pg/ml. We also measured serum CrossLaps (CTX) as another serum resorption marker. Patients had a mean Whole PTH of 95.5 pg/ml and a mesan total PTH of 155.4 pg/l (range 9 to 900). Whole PTH represented 69.1% of total PTH. Fifteen patients (62.5%) had a total PTH of less than 100. These patients had a 1-84/7-84 relationship of 1.9 +/- 1.8 while 9 patients with Total PTH more than 100 had a relationship of 1.29 +/- 0.6 (p = NS). There was a tight correlation between Whole PTH and total PTH (r = 0.98; p < 0.0001) and with serum CTX (r = 0.78; p < 0.0001). We conclude that 1-84/7-84 ratio does not seem useful in the prediction of low bone turnover and that Whole PTH does not seem to be more useful than intact PTH in the prediction of bone turnover in this population. Future studies should correlate this markers with direct measurements of bone turnover in bone biopsies to demonstrate their usefulness in the prediction of the type of renal osteodystrophy.
传统的完整甲状旁腺激素(PTH)检测不仅能检测PTH 1-84,还能检测在肾衰竭时蓄积的无活性片段(如PTH 7-84)。最近开发出了一种新的PTH检测方法,该方法仅测量真正的1-84 PTH(全段PTH或CAP检测法,Scantibodies公司)。由于7-84 PTH片段对1-84 PTH的骨效应具有拮抗作用,莫尼埃 - 福热尔提出1-84/7-84 PTH比值小于1可预测低骨转换。我们评估了CAP检测法以及1-84/7-84 PTH比值作为24例腹膜透析(PD)患者骨转换标志物的效用。如果患者的总PTH(类似于完整PTH)低于100 pg/ml,则被归类为低骨转换。我们还测量了血清I型胶原交联C末端肽(CTX)作为另一种血清骨吸收标志物。患者的平均全段PTH为95.5 pg/ml,平均总PTH为155.4 pg/l(范围为9至900)。全段PTH占总PTH的69.1%。15例患者(62.5%)的总PTH低于100。这些患者的1-84/7-84比值为1.9±1.8,而9例总PTH高于100的患者的该比值为1.29±0.6(p值无统计学意义)。全段PTH与总PTH之间存在紧密相关性(r = 0.98;p < 0.0001),与血清CTX也存在紧密相关性(r = 从0.78;p < 0.0001)。我们得出结论,1-84/7-84比值似乎对预测低骨转换无用,并且在该人群中,全段PTH在预测骨转换方面似乎并不比完整PTH更有用。未来的研究应将这些标志物与骨活检中骨转换的直接测量结果相关联,以证明它们在预测肾性骨营养不良类型方面的效用。